Work

Comparing Neuro-QOL Outcomes in a 2 year longitudinal assessment of new users of natalizumab and fingolimod with MS (P3.340)

Year: 2017

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.88.16_supplement.p3.340

Authors: Kavita Nair, Stefan Sillau, Diane Fairclough, Deborah Miller, John Foley, Brooke Valdez, Lindsay Hosford, Tammy Hoyt, Laura Seawright, John Corboy, Enrique Alvarez, Terrie Livingston

Institutions: Cleveland Clinic, Rocky Mountain Multiple Sclerosis Clinic, University of Colorado Anschutz, Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2781904792

FWCI:

Cites:

Cited by:

Related to: 10